Ajinomoto Co., Inc. has signed a licensing agreement with Astellas Pharma Inc. for the use of AJICAP—an antibody-drug conjugate (ADC) development and manufacturing technology—as part of its CDMO ...

GSK plc ( NYSE: GSK) and Syndivia on Monday announced an agreement granting GSK exclusive worldwide rights to develop and ...

The concern is that over time, multi-vendor support and the freedom to experiment could be compromised in favor of Qualcomm’s ...

IntoCell Inc. (KOSDAQ: 287840), a biotechnology company developing next-generation payload and linker technologies for antibody–drug conjugates (ADCs), and Xcellon Biologics, a U.S.-based contract ...

Antibody-drug conjugates (ADCs) represent a new era in cancer therapy, harnessing the precision of antibodies to deliver ...

After introducing the 1 GHz RA8T2 MCU earlier this month, Renesas has recently expanded its RA8 lineup with the RA8D2 and ...

Learn everything about the ROG Xbox Ally X, from its powerful AMD Ryzen Z1 Extreme chip to its ergonomic design and display ...

After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...

Infineon’s OktoberTech in Silicon Valley provided a glimpse of the shift in power architecture with hot-swap controllers, ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 1 clinical study titled A Phase 1 ...